Goodrx Holdings Inc (GDRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has a cash flow conversion efficiency ratio of 0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.02 Million) by net assets ($600.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Goodrx Holdings Inc to measure how many days the company can operate on defensive assets alone.
Goodrx Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Goodrx Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Goodrx Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Goodrx Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xinjiang Zhundong Petroleum
SHE:002207
|
-2.659x |
|
Cerro de Pasco Resources Inc.
V:CDPR
|
N/A |
|
Ag Growth International Inc
TO:AFN
|
-0.005x |
|
Hydratec Industries NV
AS:HYDRA
|
0.172x |
|
First Community Corporation
NASDAQ:FCCO
|
0.057x |
|
NI Holdings Inc
NASDAQ:NODK
|
-0.184x |
|
Anhui Fengxing Wear Resistant Materials Co Ltd
SHE:002760
|
0.032x |
|
K&F Growth Acquisition Corp. II Unit
NASDAQ:KFIIU
|
0.000x |
Annual Cash Flow Conversion Efficiency for Goodrx Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Goodrx Holdings Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Goodrx Holdings Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $724.66 Million | $183.89 Million | 0.254x | +39.82% |
| 2023-12-31 | $761.96 Million | $138.29 Million | 0.181x | +0.75% |
| 2022-12-31 | $814.83 Million | $146.78 Million | 0.180x | -16.20% |
| 2021-12-31 | $831.68 Million | $178.78 Million | 0.215x | +16.43% |
| 2020-12-31 | $711.36 Million | $131.34 Million | 0.185x | +341.10% |
| 2019-12-31 | $-1.09 Billion | $83.29 Million | -0.077x | -96.71% |
| 2018-12-31 | $-1.16 Billion | $45.25 Million | -0.039x | -- |
About Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more